Omnipaque 140 mg I/ml Solution for Injection (Glass) Ireland - English - HPRA (Health Products Regulatory Authority)

omnipaque 140 mg i/ml solution for injection (glass)

ge healthcare as - iohexol - solution for injection - 140 milligram(s) - watersoluble, nephrotropic, low osmolar x-ray contrast media; iohexol

Omnipaque 180 mg I/ml Solution for Injection (Glass) Ireland - English - HPRA (Health Products Regulatory Authority)

omnipaque 180 mg i/ml solution for injection (glass)

ge healthcare as - iohexol - solution for injection - 180 milligram(s) - watersoluble, nephrotropic, low osmolar x-ray contrast media; iohexol

Omnipaque 240 mg I/ml Solution for Injection (Glass) Ireland - English - HPRA (Health Products Regulatory Authority)

omnipaque 240 mg i/ml solution for injection (glass)

ge healthcare as - iohexol - solution for injection - 240 milligram(s) - watersoluble, nephrotropic, low osmolar x-ray contrast media; iohexol

Omnipaque 300 mg I/ml Solution for Injection (Glass) Ireland - English - HPRA (Health Products Regulatory Authority)

omnipaque 300 mg i/ml solution for injection (glass)

ge healthcare as - iohexol - solution for injection - 300 milligram(s) - watersoluble, nephrotropic, low osmolar x-ray contrast media; iohexol

Omnipaque 350 mg I/ml Solution for Injection (Glass) Ireland - English - HPRA (Health Products Regulatory Authority)

omnipaque 350 mg i/ml solution for injection (glass)

ge healthcare as - iohexol - solution for injection - 350 milligram(s) - watersoluble, nephrotropic, low osmolar x-ray contrast media; iohexol

Omnipaque 300 mg I/ml Solution for Injection (Polypropylene) Ireland - English - HPRA (Health Products Regulatory Authority)

omnipaque 300 mg i/ml solution for injection (polypropylene)

ge healthcare as - iohexol - solution for injection - 300 milligram(s) - watersoluble, nephrotropic, low osmolar x-ray contrast media; iohexol

Omnipaque 240 mg I/ml Solution for Injection (Polypropylene) Ireland - English - HPRA (Health Products Regulatory Authority)

omnipaque 240 mg i/ml solution for injection (polypropylene)

ge healthcare as - iohexol - solution for injection - 240 milligram(s) - watersoluble, nephrotropic, low osmolar x-ray contrast media; iohexol

Omnipaque 350 mg I/ml Solution for Injection (Polypropylene) Ireland - English - HPRA (Health Products Regulatory Authority)

omnipaque 350 mg i/ml solution for injection (polypropylene)

ge healthcare as - iohexol - solution for injection - 350 milligram(s) - watersoluble, nephrotropic, low osmolar x-ray contrast media; iohexol

Omnipaque New Zealand - English - Medsafe (Medicines Safety Authority)

omnipaque

ge healthcare limited t/a ge healthcare - medical diagnostics - iohexol 302 mg/ml equivalent to 140 mg i/ml - solution for injection - 140 mg i/ ml - active: iohexol 302 mg/ml equivalent to 140 mg i/ml excipient: sodium calcium edetate trometamol water for injection

Omnipaque 240 iohexol 10.36g/20mL Injection Australia - English - Department of Health (Therapeutic Goods Administration)

omnipaque 240 iohexol 10.36g/20ml injection

ge healthcare australia pty ltd - iohexol, quantity: 518 mg/ml (equivalent: iodine, qty 240 mg/ml) - injection, solution - excipient ingredients: trometamol; sodium calcium edetate; hydrochloric acid; water for injections - indications as at 12 november 2003: intravascular: omnipaque is indicated in adults for angiography, excretory urography and contrast enhancement in computerised tomography. in children, omnipaque is indicated for angiography and urography. oral/body cavities: omnipaque is indicated in adults for arthrography, endoscopic retrograde pancreatography (erp), endoscopic retrograde cholangiopancreatography (ercp), herniography, hysterosalpingography and in adults, children and premature babies for studies of the gastrointestinal tract.